Advanced Life Sciences to Host Conference Call to Discuss Data From,Cethromycin's First of Two Phase 3 Pneumonia Trials ( CHICAGO June 29 2007 /PRNewswire-Fir...)

Advanced Life Sciences to Host Conference Call to Discuss Data From,Cethromycin's First of Two Phase 3 Pneumonia Trials

CHICAGO, June 29, 2007 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. , today announced that it will host a conference call and live webcast at 10:00 am (EDT) on Monday, July 2, 2007 to discuss data from Trial CL-06, the first of two pivotal Phase 3 clinical trials designed to assess the safety and effectiveness of cethromycin, a novel once-a-day antibiotic, for the treatment of community acquired pneumonia (CAP).

Conference Call Details:

The conference call will be webcast simultaneously over the Internet. Please visit the Investor Relations section of the Advanced Life Sciences corporate website http://www.advancedlifesciences.com. Alternatively, callers may participate in the conference call by dialing 800-561-2601(domestic) or 617-614-3518 (international). The passcode for the conference call is 84510433. A replay of the conference call will be available until August 2, 2007. Callers may access the telephone replay by dialing 888-286-8010 (domestic) or 617-801-6888 (international), passcode 90055877.

About Advanced Life Sciences

Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and inflammation. The Company's lead candidate, cethromycin, is a novel once-a-day antibiotic in late-stage clinical development for the treatment of respiratory tract infections including CAP. For more information, please visit us on the web at http://www.advancedlifesciences.com.

Forward-Looking Statements

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forw
'"/>

Page: 1 2
Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
4. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
5. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
6. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
7. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
8. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
9. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
10. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
11. GSKS Pazopanib Shows Positive Results in Patients with Advanced Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma

Post Your Comments:

(Date:11/9/2009)... Nov. 9 Cardiac Scienc...in automated external defibrillator ( AED ) and ...nced revenue of $38.9 million for the third quarte...ous guidance. The Company also recorded a charge o...d a non-cash charge of $44.0 million to increase i...

(Date:11/9/2009)...Nov. 9 Boston Scientific...edule of events at the 38th annual Global Congress...uns from November 15-19 in Orlando, Florida. Resu...aturing the Company,s Urology/Gynecology products,... mid-urethral sling systems used to treat pelvic f...

(Date:11/9/2009)...NCETON, N.J., Nov. 9 Pha...t will present at the Sixth Annual Lazard Capital ... be held at the St Regis Hotel in New York City (N...sset,s President and Chief Executive Officer, will...November 18, 2009 at 3:45 PM (ET). ,, To access...

[0] Cardiac Science Announces Third Quarter Results [0] Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress [0] Pharmasset to Present at Lazard Capital Markets Healthcare Conference

...Nektar Therapeutics,(Nasdaq: NKTR ) announced tod...for its pipeline programs will be presented at num...ing months. These presentations will,highlight Nek... oncology,anti-infectives and central nervous syst... molecule PEGylation and liquid aerosol platforms....

...w devices and research for,mechanical circulatory ...,of Health (NIH) National Heart, Lung, and Blood I...gram will be discussed at the International Societ...Annual Meeting and,Scientific Sessions. The meetin...ey Place and Hynes Convention Center., The use of...

Other Medicine Technology:Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings 2 Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings 3 Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings 4 New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting 2

Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting

(Date:11/9/2009)...HINGTON, Nov. 9 The Churchill Ce...ward For Leadership to J.W. "Bill" Marriott for hi...gh progressive free market practices and fostering...Mr. Marriott will receive his award at a ceremony ...on D.C. Four Seasons Hotel. ,, "This is a test...

(Date:11/9/2009)...lped men and women almost equally, study finds, ,...e widely used clot-dissolving drug Plavix (clopido...analysis of major clinical trials has found. , ...n treating both men and women with this very impor...f cardiovascular thrombosis at New York University...

(Date:11/9/2009)...n of plans finds differences in mood despite simil...hDay News) -- Both a high-fat, low-carbohydrate di...t, high-carb diet appear to help people lose pound...? Only the low-fat diets will result in long-term ...ov. 9 issue of Archives of Internal Medicine . ,...

(Date:11/9/2009)... Tomorrow may be too late when it ...ion, according to TOPS Club, Inc. (Take Off Pounds...nization. , (Vocus) Novem...mes to preventing or improving a diabetes conditio...ensibly), the nonprofit weight-loss support organi...

(Date:11/9/2009)...ANON, Tenn., Nov. 9 Health Connect...ced it will host their inaugural Hospital O.R. and...at the Marriott Renaissance Hotel in Nashville, Te...e than 100 hospital operating room directors and m...lth systems in the country. Some of the confirmed ...

Breaking Medicine News(10 mins):Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2 Health News:No Gender Gap Found for Clot-Busting Drug 2 Health News:No Gender Gap Found for Clot-Busting Drug 3 Health News:To Feel Better, Low-Fat Diet May Be Best 2 Health News:To Feel Better, Low-Fat Diet May Be Best 3 Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2 Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3 Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2

[0] J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership [0] No Gender Gap Found for Clot-Busting Drug [0] To Feel Better, Low-Fat Diet May Be Best [0] Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says [1] Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference

...tra El Cancer, an,organization dedicated to improv...ancer and their families, will host its Annual Hol...ients this Saturday, December 13, 2008. , Ch...ebrating holiday traditions. In addition to the s...

...Vital Images, Inc. (Nasdaq: VTAL ) , a leadin...on and analysis solutions, has named Ray A. Ghanba...d Products, a new position at ViTAL. Ghanbari repo...elopment and driving strategic business planning. ...

... this,afternoon by some major Michigan newspapers,...rmation about Executive Order (EO) budget cuts pro...y, the stories mistakenly reported:,"Another $5.3 ...ealth care treatment delivered to Medicaid patient...

...ER treatment, elective procedures, study says , ...re could be a shortage of 1,300 general surgeons i...at shortage could increase to 6,000 by 2050, a new...ency departments. A shortage of general surgeons m...

...consecutive year,hundreds of Conseco employees in ...eer for the needy of central Indiana as part of th...oliday season, Conseco partners with the United Ch...volunteers often add their,own donations and perfo...

...ernacional,S.A.B. de C.V. (BMV: LAB) ("Genomma Lab...unter ("OTC") pharmaceuticals and personal care pr...uidance. The Company expects to reach,organic gro...sed on the organic growth of core products (produc...

Other Medicine News:Health News:PADRES Contra El Cancer to Host its 10th Annual Posada Holiday Celebration for Children with Cancer 2 Health News:Vital Images Names Healthcare Veteran Ray Ghanbari Executive Vice President of Strategy and Products 2 Health News:Vital Images Names Healthcare Veteran Ray Ghanbari Executive Vice President of Strategy and Products 3 Health News:U.S. May Soon Face Shortage of General Surgeons 2 Health News:Conseco Employees Provide Holiday Cheer for 40 Central Indiana Families 2 Health News:Genomma Lab Announces 2009 Earnings Guidance 2

PADRES Contra El Cancer to Host its 10th Annual Posada Holiday Celebration for Children with Cancer Vital Images Names Healthcare Veteran Ray Ghanbari Executive Vice President of Strategy and Products Michigan Governor's Executive Order Budget Cuts Do Not Cut Payments to Medicaid Patients U.S. May Soon Face Shortage of General Surgeons Conseco Employees Provide Holiday Cheer for 40 Central Indiana Families Genomma Lab Announces 2009 Earnings Guidance

...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...

Medicine Products:

Vancocin, Peak Level Valproic Acid, Free & Total Valley Fever (Serum)Valium

( CHICAGO June 29 2007 /PRNewswire-Fir...)Advanced Life Sciences to Host Conference Call to Discuss Data From,Cethromycin's First of Two Phase 3 Pneumonia Trials,Health